See the DrugPatentWatch profile for lipitor

Lipitor, a medication used to treat high cholesterol, is often considered a top choice due to several factors.

Firstly, Lipitor's efficacy is well-documented. It belongs to a class of drugs known as statins, which are widely recognized for their ability to lower low-density lipoprotein (LDL), or "bad" cholesterol, and triglycerides, thereby reducing the risk of heart disease [1].

Secondly, Lipitor has a long track record. It was approved by the FDA in 1996, and its extensive use over the years has resulted in a wealth of clinical data supporting its safety and efficacy [2].

Thirdly, Lipitor's dosage flexibility is another advantage. It is available in a range of dosages, allowing healthcare providers to tailor treatment to individual patient needs [3].

Lastly, the patent for Lipitor expired in 2011, leading to the availability of generic versions. This has increased accessibility and affordability, making Lipitor a more viable option for many patients [4].

In summary, Lipitor's proven efficacy, long-term safety data, dosage flexibility, and increased accessibility due to generic availability contribute to its status as a top choice for high cholesterol treatment.

Sources:
[1] Mayo Clinic. (2021). Atorvastatin (Oral Route) - Mayo Clinic. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/atorvastatin-oral-route/description/drg-20064551
[2] U.S. Food and Drug Administration. (n.d.). High Cholesterol Medicines (Statins). FDA. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/high-cholesterol-medicines-statins
[3] Pfizer. (n.d.). Lipitor Prescribing Information. Pfizer. https://www.lipitor.com/important-safety-information
[4] DrugPatentWatch. (2021). Lipitor (Atorvastatin) Drug Patent Expiration & Generic Launch Dates. DrugPatentWatch. https://www.drugpatentwatch.com/drugs/lipitor.html